BR0309018A - Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica - Google Patents

Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica

Info

Publication number
BR0309018A
BR0309018A BR0309018-3A BR0309018A BR0309018A BR 0309018 A BR0309018 A BR 0309018A BR 0309018 A BR0309018 A BR 0309018A BR 0309018 A BR0309018 A BR 0309018A
Authority
BR
Brazil
Prior art keywords
preparation
dihydro
heteroaryl
therapeutic application
group
Prior art date
Application number
BR0309018-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Jacques Froissant
Benoit Marabout
Frank Marguet
Frederic Puech
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BR0309018A publication Critical patent/BR0309018A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
BR0309018-3A 2002-04-03 2003-04-02 Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica BR0309018A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204158A FR2838124B1 (fr) 2002-04-03 2002-04-03 Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR2003/001027 WO2003082874A2 (fr) 2002-04-03 2003-04-02 DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
BR0309018A true BR0309018A (pt) 2005-02-01

Family

ID=28052083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309018-3A BR0309018A (pt) 2002-04-03 2003-04-02 Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica

Country Status (28)

Country Link
US (4) US7235554B2 (cg-RX-API-DMAC10.html)
EP (1) EP1492792B1 (cg-RX-API-DMAC10.html)
JP (2) JP4575670B2 (cg-RX-API-DMAC10.html)
KR (1) KR100975999B1 (cg-RX-API-DMAC10.html)
CN (2) CN100406459C (cg-RX-API-DMAC10.html)
AT (1) ATE321763T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003240930B2 (cg-RX-API-DMAC10.html)
BR (1) BR0309018A (cg-RX-API-DMAC10.html)
CA (1) CA2481460C (cg-RX-API-DMAC10.html)
CY (1) CY1104998T1 (cg-RX-API-DMAC10.html)
DE (1) DE60304327T2 (cg-RX-API-DMAC10.html)
DK (1) DK1492792T3 (cg-RX-API-DMAC10.html)
EA (1) EA007219B1 (cg-RX-API-DMAC10.html)
ES (1) ES2261940T3 (cg-RX-API-DMAC10.html)
FR (1) FR2838124B1 (cg-RX-API-DMAC10.html)
HR (1) HRP20040911B1 (cg-RX-API-DMAC10.html)
IL (2) IL164257A0 (cg-RX-API-DMAC10.html)
IS (1) IS2483B (cg-RX-API-DMAC10.html)
ME (2) MEP23708A (cg-RX-API-DMAC10.html)
MX (1) MXPA04009635A (cg-RX-API-DMAC10.html)
NO (1) NO329426B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ535741A (cg-RX-API-DMAC10.html)
PL (1) PL372617A1 (cg-RX-API-DMAC10.html)
PT (1) PT1492792E (cg-RX-API-DMAC10.html)
RS (1) RS51244B (cg-RX-API-DMAC10.html)
UA (1) UA77273C2 (cg-RX-API-DMAC10.html)
WO (1) WO2003082874A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200407945B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017932A1 (en) * 2004-08-18 2006-02-23 Genesense Technologies Inc. Small interfering rna molecules against ribonucleotide reductase and uses thereof
JP2009504752A (ja) * 2005-08-19 2009-02-05 シェーリング コーポレイション 治療剤としての縮合三環式mGluR1アンタゴニスト
US20120041211A1 (en) * 2009-01-30 2012-02-16 Sythana Suresh Kumar Novel process for preparing carboxy-containing pyrazoleamido compounds 597
CN105330665B (zh) * 2015-11-04 2017-10-03 衡阳师范学院 一种抑制激肽释放酶klk7的化合物、制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Also Published As

Publication number Publication date
IS7478A (is) 2004-09-30
AU2003240930B2 (en) 2009-07-30
RS51244B (sr) 2010-12-31
KR20040094904A (ko) 2004-11-10
NO329426B1 (no) 2010-10-18
EP1492792B1 (fr) 2006-03-29
US7405306B2 (en) 2008-07-29
US7235554B2 (en) 2007-06-26
JP4575670B2 (ja) 2010-11-04
KR100975999B1 (ko) 2010-08-17
CA2481460A1 (en) 2003-10-09
EP1492792A2 (fr) 2005-01-05
HK1074632A1 (zh) 2005-11-18
ES2261940T3 (es) 2006-11-16
UA77273C2 (en) 2006-11-15
EA007219B1 (ru) 2006-08-25
JP2010248221A (ja) 2010-11-04
NZ535741A (en) 2007-03-30
DE60304327D1 (de) 2006-05-18
WO2003082874A2 (fr) 2003-10-09
JP2005527566A (ja) 2005-09-15
CN1656099A (zh) 2005-08-17
DK1492792T3 (da) 2006-08-14
DE60304327T2 (de) 2006-12-28
JP5277208B2 (ja) 2013-08-28
HK1102371A1 (en) 2007-11-16
US20070219202A1 (en) 2007-09-20
CN100406459C (zh) 2008-07-30
MXPA04009635A (es) 2005-07-13
PT1492792E (pt) 2006-08-31
MEP23708A (en) 2010-06-10
IS2483B (is) 2008-12-15
FR2838124B1 (fr) 2004-05-28
US7323467B2 (en) 2008-01-29
ZA200407945B (en) 2005-11-30
CN100543016C (zh) 2009-09-23
US20050124615A1 (en) 2005-06-09
CA2481460C (en) 2011-02-15
US20080076775A1 (en) 2008-03-27
CY1104998T1 (el) 2009-11-04
NO20044153L (no) 2004-12-27
HRP20040911A2 (en) 2004-12-31
US20080255129A1 (en) 2008-10-16
HRP20040911B1 (en) 2012-11-30
WO2003082874A3 (fr) 2004-04-01
PL372617A1 (en) 2005-07-25
CN1970538A (zh) 2007-05-30
EA200401146A1 (ru) 2005-06-30
ME00081B (me) 2010-10-10
AU2003240930A1 (en) 2003-10-13
FR2838124A1 (fr) 2003-10-10
ATE321763T1 (de) 2006-04-15
IL164257A (en) 2009-11-18
IL164257A0 (en) 2005-12-18
RS86904A (sr) 2006-12-15

Similar Documents

Publication Publication Date Title
HRP20020712B1 (hr) Farmaceutske strukture koje sadrže derivate azetidina, novi derivati azetidina i njihovo pripremanje
BR0210538A (pt) Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7
AR011623A1 (es) Compuestos de sulfonamidas, procedimiento para prepararlos y composiciones farmaceuticas para potenciar las funciones de los glutamatoreceptores enmamiferos.
DK1025088T3 (da) Imidazolderivater og deres anvendelse som farnesylproteintransferaseinhibitorer
BRPI0519794A2 (pt) derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
BR0113173A (pt) Derivados de 4-fenil-piridina
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
BRPI0414450A (pt) derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica
BRPI0413283B8 (pt) Composto derivado de (tio)carbamoil-ciclohexano, seu processo de preparação, amina, composição farmacêutica e uso do composto
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
BR0115480A (pt) Derivados de pirimidina
BRPI0812816B8 (pt) compostos derivados de sulfonil-quinolina, ligantes com preferência para subtipo de receptor mglur1 e mglur5, processos para a preparação dos referidos compostos, formulação farmacêutica compreendedo os referidos compostos e uso dos mesmos
BRPI0414460A (pt) compostos derivados de carboxamida do tipo de amida, composição farmacêutica e respectivo uso
BR0116193A (pt) Derivados de aminotriazolpiridina como ligandos de receptores de adenosina
BR0215174A (pt) Derivados de 3-heteroaril-3,5-diidro-4-oxo-4h-piridazino[4,5-b]indol 1-carboxamida, sua preparação e sua aplicação em terapêutica
BR0213359A (pt) Aralquiltetrahidropiridinas, sua preparação e composições farmacêuticas contendo as mesmas
BR0212932A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes, composição farmacêutica contendo os mesmos e seus usos
BR0306707A (pt) Derivados de 5-(piridin-3-il)-1-azabiciclo[3.2.1]octano, sua preparação e sua aplicação em terapêutica
ME00081B (me) Derivati 3-heteroaril-3,5-dihidro-4-okso-4h-piridazino (4,5-b)- indol-1-acetamida, njihovo dobijanje i primjena u terapiji
BRPI0504780A (pt) compostos de benzotiadiazina, processo para sua preparação e composições farmacêuticas contendo os mesmos
YU16196A (sh) Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka
BR0208245A (pt) Métodos para a preparação de compostos e compostos
BR0214936A (pt) Benzotiofenos como moduladores do receptor de adenosina
BR0215672A (pt) Novos derivados de piperidinil-alquilamino-piridazinona, processo para o seu preparo e composições farmacêuticas contendo os referidos compostos
AR002015A1 (es) DERIVADOS DE ACIDO 8-OXO-5,8-DIHIDRO-6H-DIBENZO (a, g) QUINOLIZINA-13- PROPANOICO, PROCEDIMIENTO PARA SU PREPARACION Y MEDICAMENTO Y COMPOSICIONFARMACEUTICA QUE CONTIENEN A DICHOS DERIVADOS.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.